Metabolic Regulation-Mediated Reversion of the Tumor Immunosuppressive Microenvironment for Potentiating Cooperative Metabolic Therapy and Immunotherapy
Nano Letters · 2024
DOI: 10.1021/acs.nanolett.4c01307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2024. Verfasst von Ping Ji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Polymers of Ministry of Education and Department of Chemistry, Wuhan University, Wuhan 430072, P. R. China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Wuhan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor cells exhibit heightened glucose (Glu) consumption and increased lactic acid (LA) production, resulting in the formation of an immunosuppressive tumor microenvironment (TME) that facilitates malignant proliferation and metastasis. In this study, we meticulously engineer an antitumor nanoplatform, denoted as ZLGCR, by incorporating glucose oxidase, LA oxidase, and CpG oligodeoxynucleotide into zeolitic imidazolate framework-8 that is camouflaged with a red blood cell membrane. Significantly, ZLGCR-mediated consumption of Glu and LA not only amplifies the effectiveness of metabolic therapy but also reverses the immunosuppressive TME, thereby enhancing the therapeutic outcomes of CpG-mediated antitumor immunotherapy. It is particularly important that the synergistic effect of metabolic therapy and immunotherapy is further augmented when combined with immune checkpoint blockade therapy. Consequently, this engineered antitumor nanoplatform will achieve a cooperative tumor-suppressive outcome through the modulation of metabolism and immune responses within the TME.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomedical Polymers of Ministry of Education and Department of Chemistry, Wuhan University, Wuhan 430072, P. R. China.
- Institute of Precision Medicine Peking University Shenzhen Hospital, Shenzhen 518036, P. R. China.
- Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, P. R. China.
ORCID-Profile: Jun-Long Liang, Wei-Hai Chen, Xian-Zheng Zhang
Förderung
- National Key Research and Development Program of China
- Wuhan University
- National Natural Science Foundation of China
Zitieren
APA
Ji, P., Jin, X. K., Deng, X. C., Zhang, S. M., Liang, J. L., Li, Q. R., Chen, W. H., & Zhang, X. Z. (2024). Metabolic Regulation-Mediated Reversion of the Tumor Immunosuppressive Microenvironment for Potentiating Cooperative Metabolic Therapy and Immunotherapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.4c01307
Vancouver
Ji P, Jin XK, Deng XC, Zhang SM, Liang JL, Li QR, et al. Metabolic Regulation-Mediated Reversion of the Tumor Immunosuppressive Microenvironment for Potentiating Cooperative Metabolic Therapy and Immunotherapy. Nano Letters. 2024. doi:10.1021/acs.nanolett.4c01307
BibTeX
@article{Ji2024,
author = {Ji, Ping and Jin, Xiao-Kang and Deng, Xin-Chen and Zhang, Shi-Man and Liang, Jun-Long and Li, Qian-Ru and Chen, Wei-Hai and Zhang, Xian-Zheng},
title = {Metabolic Regulation-Mediated Reversion of the Tumor Immunosuppressive Microenvironment for Potentiating Cooperative Metabolic Therapy and Immunotherapy},
journal = {Nano Letters},
year = {2024},
doi = {10.1021/acs.nanolett.4c01307}
}
EUVIMED